Roche has come out of the dealmaking gate blazing so far in 2024, racking up its third deal in as many days. On Thursday, the Swiss pharma announced it is entering into a collaboration and licensing agreement with Massachusetts-based MOMA Therapeutics for $66 million upfront.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,